Increased serum FGF21 concentration may also be a compensatory response to comorbid metabolic diseases that caused HFpHF, such as diabetes and obesity, which caused massive secretion of FGF21 from liver and adipose tissue. This evidence concerns the gene FGF21 and obesity disorder.